For patients experiencing increased rates of infection or adverse events on anti-CD20 therapy, switching to a less immunosuppressive option may be a safe option, data show.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/new-data-support-medication-switch-select-ms-patients-2026a1000jel?src=rss
Author :
Publish date : 2026-06-10 10:02:00
Copyright for syndicated content belongs to the linked Source.
